Novotech White Papers

  1. Rare Disease – 2018-2022 Global Clinical Trial Landscape 11/7/2023

    Discover why the collaboration and expertise of organizations are vital in advancing rare disease research and improving the lives of millions affected.

  2. Cell And Gene Therapies Global Clinical Trial Landscape (2018-2022) 9/15/2023

    Dive into how the advancements in technology are heralding a brighter future for patients worldwide, offering new hope and improved healthcare outcomes.

  3. Oncolytic Virus Therapies – Global Clinical Trial Landscape - Focus On Asia Pacific 9/11/2023

    Explore the global landscape of oncolytic virus clinical trials, with a particular focus on trends in the Asia Pacific region.

  4. RNA Therapies – Global Clinical Trial Landscape - Focus On Asia Pacific 5/17/2023

    Learn about the global clinical trial landscape of RNA therapy, with emphasis on trends in the Asia Pacific, and recent advancements in the field.

  5. Phase I Trials Global Clinical Trial Landscape – Focus On Asia Pacific 5/9/2023

    Unearth key trends in global Phase I trials, including highlights from the top therapeutic areas, indications, and biologic drug types in popular trial regions of Asia Pacific, the United States, and Europe.

  6. Global Outlook Of Multi-Specific Monoclonal Antibodies: Asia Pacific Focus 5/9/2023

    Learn about the global clinical trial landscape of multi-specific monoclonal antibodies (Mabs), with emphasis on trends in the Asia Pacific, and recent advancements in the field.

  7. Capitalize On Regulatory Expertise To Simplify FDA Complexities 5/9/2023

    Get an overview of the global approval landscape, pathways to approval, and the importance of a robust clinical development program as made possible with the help of an experienced CRO.

  8. Antibody Drug Conjugates: Global Trial Landscape - Focus On Asia Pacific 5/9/2023

    Gain a better understanding of the global clinical trial landscape of antibody drug conjugates (ADCs) and their trends in the Asia Pacific.

  9. C3 Glomerulopathy: The Asia Pacific Clinical Trial Landscape 1/6/2023

    C3 Glomerulopathy (C3G) is a complex, rare complement-mediated renal disease. Find out its effects in the Asia Pacific.

  10. Diabetic Retinopathy: The Asia Pacific Clinical Trial Landscape 1/6/2023

    Diabetic Retinopathy (DR) is the leading cause of vision loss in working-age populations, and one of the main complications of Diabetes Mellitus (DM). Read about the effects of this disease.